The Salvation Army has received a $45,000 donation from Dr. Buzz Aldrin, Apollo XI Lunar Module Pilot, USAF Colonel and Moonwalker, in support of the organization’s ongoing relief efforts to serve vulnerable Americans, particularly those impacted by COVID-19.

“Since last March, The Salvation Army has been hard at work serving the increase of people in need as a result of the economic and emotional impact of the pandemic,” said Commissioner Kenneth G. Hodder, National Commander of The Salvation Army. “Through donors like Dr. Buzz Aldrin, we’re able to continue providing support to those most affected by the pandemic. We can’t thank Dr. Aldrin enough for his generosity.”

Donations made to The Salvation Army provide programs and services to more than 23 million people each year. Since the start of the pandemic, The Salvation Army has provided more than 225 million meals, 1.7 million nights of shelter, and 905,000 instances of emotional and spiritual care to individuals.

Dr. Aldrin’s experience quarantining along with fellow astronauts, Neil Armstrong and Michael Collins, following their lunar landing in 1969 has made him a voice of hope and inspiration through the pandemic. The donation to The Salvation Army adds to the growing list of support efforts for COVID-19 victims that Dr. Aldrin has led.

“The pandemic has forced all of us to experience some form of isolation over the last year,” said Dr. Aldrin. “Many were able to quarantine in the comfort of their own home, but not everyone has been so lucky. The pandemic has displaced many individuals and families, so supporting organizations like The Salvation Army is crucial – they serve those in need when they have nowhere else to turn.”

comments powered by Disqus

Latest news

Cool Comedy • Hot Cuisine Raises Over $1.3 Million for Scleroderma Research Foundation

Cool Comedy • Hot Cuisine Raises Over $1.3 Million for Scleroderma Research Foundation Nov 5, 2024

Last week, in a special evening honoring John Mayer and Jeff Ross, Cool Comedy • Hot Cuisine raised more than $1.3 million for the Scleroderma Research Foundation (SRF)—the country’s first and leading nonprofit investor in medical research into scleroderma. More
More news